“Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study”., Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023061, Oct. 2023, doi: 10.4084/MJHID.2023.061.